These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8620479

  • 1. Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein.
    Reisfeld RA, Gillies SD, Mendelsohn J, Varki NM, Becker JC.
    Cancer Res; 1996 Apr 15; 56(8):1707-12. PubMed ID: 8620479
    [Abstract] [Full Text] [Related]

  • 2. Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response.
    Qin Z, Blankenstein T.
    Cancer Res; 1995 Nov 01; 55(21):4747-51. PubMed ID: 7585497
    [Abstract] [Full Text] [Related]

  • 3. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins.
    Becker JC, Pancook JD, Gillies SD, Mendelsohn J, Reisfeld RA.
    Proc Natl Acad Sci U S A; 1996 Apr 02; 93(7):2702-7. PubMed ID: 8610104
    [Abstract] [Full Text] [Related]

  • 4. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
    Sabzevari H, Reisfeld RA.
    Cancer Res; 1993 Oct 15; 53(20):4933-7. PubMed ID: 8402683
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
    Retter MW, Johnson JC, Peckham DW, Bannink JE, Bangur CS, Dresser K, Cai F, Foy TM, Fanger NA, Fanger GR, Woda B, Rock KL.
    Cancer Res; 2005 Jul 15; 65(14):6425-34. PubMed ID: 16024647
    [Abstract] [Full Text] [Related]

  • 6. Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.
    Cassard L, Cohen-Solal JF, Galinha A, Sastre-Garau X, Mathiot C, Galon J, Dorval T, Bernheim A, Fridman WH, Sautès-Fridman C.
    J Clin Invest; 2002 Nov 15; 110(10):1549-57. PubMed ID: 12438452
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.
    Liu Y, Zheng M, Lai Z, Xiong D, Fan D, Xu Y, Peng H, Shao X, Xu Y, Yang M, Wang J, Liu H, Xie Y, Yang C, Zhu Z.
    Cancer Lett; 2004 Mar 18; 205(2):143-53. PubMed ID: 15036646
    [Abstract] [Full Text] [Related]

  • 8. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF, de Paus RA, Kluin-Nelemans HC, Kluin PM, van Bergen CA, Munro AJ, Hale G, Willemze R, Falkenburg JH.
    Exp Hematol; 1996 Jul 18; 24(8):919-26. PubMed ID: 8690051
    [Abstract] [Full Text] [Related]

  • 9. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.
    Rofstad EK, Mathiesen B, Kindem K, Galappathi K.
    Cancer Res; 2006 Jul 01; 66(13):6699-707. PubMed ID: 16818644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 12. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
    Shibuya M, Saijo N, Ozaki A, Beppu Y, Shimizu E, Takizawa T, Hoshi A.
    Gan To Kagaku Ryoho; 1983 Aug 15; 10(8):1781-6. PubMed ID: 6882003
    [Abstract] [Full Text] [Related]

  • 13. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H, Horikawa T, Hara I, Fukunaga A, Oniki S, Oka M, Nishigori C, Ichihashi M.
    Exp Dermatol; 2004 Oct 15; 13(10):613-20. PubMed ID: 15447721
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 15; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 15. Organ-specific metastases in immunodeficient mice injected with human melanoma cells: a quantitative pathological analysis.
    Byers HR, Etoh T, Lee KW, Mihm MC, Gattoni-Celli S.
    Melanoma Res; 1993 Aug 15; 3(4):247-53. PubMed ID: 8219757
    [Abstract] [Full Text] [Related]

  • 16. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS.
    Cancer Res; 1994 Mar 15; 54(6):1561-5. PubMed ID: 7511044
    [Abstract] [Full Text] [Related]

  • 18. TALL-104 cell therapy of human solid tumors implanted in immunodeficient (SCID) mice.
    Cesano A, Visonneau S, Santoli D.
    Anticancer Res; 1998 Mar 15; 18(4A):2289-95. PubMed ID: 9703868
    [Abstract] [Full Text] [Related]

  • 19. Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody.
    Nakamura K, Hanibuchi M, Yano S, Tanaka Y, Fujino I, Inoue M, Takezawa T, Shitara K, Sone S, Hanai N.
    Cancer Res; 1999 Oct 15; 59(20):5323-30. PubMed ID: 10537316
    [Abstract] [Full Text] [Related]

  • 20. Mice with a targeted mutation in lymphotoxin-alpha exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment.
    Ito D, Back TC, Shakhov AN, Wiltrout RH, Nedospasov SA.
    J Immunol; 1999 Sep 01; 163(5):2809-15. PubMed ID: 10453025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.